Get started
Author

Derek Dinart

Liquid versus tissue biopsy for detecting actionable alterations according to the ESMO Scale for Clinical Actionability of molecular Targets in patients with advanced cancer: a study from the French National Center for Precision Medicine (PRISM)
2022 · A. Bayle, F. Peyraud, et al. · Annals of Oncology · 64
PDF
Optimal biological dose: a systematic review in cancer phase I clinical trials
2021 · J. Fraisse, D. Dinart, et al. · BMC Cancer · 53
PDF
Meta-analyses evaluating surrogate endpoints for overall survival in cancer randomized trials: A critical review
2017 · Marion Savina, Sophie Gourgou, et al. · Critical Reviews in Oncology/Hematology · 51
Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial
2021 · Antoine Italiano, Derek Dinart, et al. · BMC Cancer · 23
PDF
Contrast-enhanced intra-operative ultrasound as a clinical decision making tool during surgery for colorectal liver metastases: The ULIIS study
2019 · G. Desolneux, M. Isambert, et al. · European Journal of Surgical Oncology · 14
PDF
Concomitant chemotherapy in trimodal treatment of patients with muscle invasive bladder cancer: A systematic review of prospective trials
2024 · Camille Baudelin, Paul Sargos, et al. · Critical Reviews in Oncology/Hematology · 11
Feasibility of high-throughput sequencing in clinical routine cancer care: lessons from the cancer pilot project of the France Genomic Medicine 2025 plan
2020 · Céline Auzanneau, Delphine Bacq, et al. · ESMO Open · 11
Outcome of Patients with Soft-Tissue Sarcomas: An Age-Specific Conditional Survival Analysis
2019 · Kevin Bourcier, Derek Dinart, et al. · The Oncologist · 9
PDF
Results of a phase Ib study of olaparib with concomitant radiotherapy in soft-tissue sarcoma: a French sarcoma group study
2025 · P. Sargos, M.P. Sunyach, et al. · Annals of Oncology · 7
PDF
Chemotherapy following immune checkpoint inhibitors in patients with locally advanced or metastatic urothelial carcinoma
2022 · Lucie Meynard, Derek Dinart, et al. · European Journal of Cancer · 7
PDF
GUIP1: a R package for dose escalation strategies in phase I cancer clinical trials
2020 · D. Dinart, J. Fraisse, et al. · BMC Medical Informatics and Decision Making · 5
PDF
Preliminary results of a phase IB study of olaparib with concomitant radiotherapy in locally advanced/unresectable soft-tissue sarcoma from the French Sarcoma Group.
2022 · Paul Sargos, Marie Pierre Sunyach, et al. · Journal of Clinical Oncology · 4
Metastatic chondrosarcoma, patterns of care, and outcomes of patients in a real‐life national setting over a decade
2025 · Coline Ducrot, Derek Dinart, et al. · International Journal of Cancer · 3
Evolution of Patterns of Care and Outcomes in the Real-Life Setting for Patients with Metastatic GIST Treated in Three French Expert Centers over Three Decades
2023 · Maud Toulmonde, Derek Dinart, et al. · Cancers · 3
PDF
Metastatic osteosarcoma, patterns of care and outcomes of patients in a real‐life national setting over a decade
2025 · Mathilde Reich, Derek Dinart, et al. · International Journal of Cancer · 2
1968P Metastatic Ewing sarcoma, patterns of care and outcomes of patients in a real-life setting: The Metabone national observational study
2023 · C. Ducrot, D. Dinart, et al. · Annals of Oncology · 2
PDF
Sample size estimation for cancer randomized trials in the presence of heterogeneous populations
2021 · Derek Dinart, Carine Bellera, et al. · Biometrics · 2
Programme MULTIPLI : développement d’essais cliniques par séquençage à haut débit et pour des cancers avancés
2018 · D. Dinart, A. Italiano, et al. · Revue d Épidémiologie et de Santé Publique · 2
Beyond Surgical Margins: Fully Mature Tertiary Lymphoid Structures (fmTLSs) Are Predictive Biomarkers for Local Recurrence in Primary Soft-Tissue Sarcomas
2026 · Audrey Michot, Lucile Vanhersecke, et al. · Cancers · 1
P10 - Which methods can be used to account for indication bias in survival analyses of real-world data: application to DEEPSARC study
2025 · N. Huchet, J. Blay, et al. · Journal of Epidemiology and Population Health · 1
The Growth Modulation Index (GMI) as an Efficacy Outcome in Cancer Clinical Trials: A Scoping Review with Suggested Reporting Guidelines
2025 · Kilian Trin, Cynthia Dalleau, et al. · Current Oncology Reports · 1
PDF
Sample size estimation for recurrent event data using multifrailty and multilevel survival models
2024 · Derek Dinart, Carine Bellera, et al. · Journal of Biopharmaceutical Statistics · 1
1971P Metastatic osteosarcoma, patterns of care and outcomes of patients in a real-life setting: The Metabone national observational study
2023 · M. Reich, D. Dinart, et al. · Annals of Oncology · 1
PDF
Contrast-enhanced intra-operative ultrasound as a clinical decision making tool during surgery for colorectal liver metastases: The ULIIS study.
2018 · Serge Evrard, Grégoire Désolneux, et al. · Journal of Clinical Oncology · 1
Empirical Comparison of Win Ratio and Joint Frailty Models for Recurrent Event Endpoints With Applications in Oncology and Cardiology
2026 · Adrien Orué, Derek Dinart, et al. · Statistics in Medicine
Works count: 53
Citation count: 279
H-index: 8
I10-index: 7
Year
Topic
Type